Drugindustrydaily

View Archived Issues

Oct. 24, 2017

Vol. 16
No. 205

Headlines

Boehringer Sues Five Generics Companies to Protect its Gilotrif Lung Cancer Therapy

Over the past month, Boehringer Ingelheim has sued five manufacturers seeking to produce generic versions of the company’s Gilotrif lung cancer treatment — most recently naming Sandoz and Sun Pharmaceutical. Read More

EMA’s PRAC Recommends New Safety Warnings and Side Effect Labeling

The European Medicines Agency’s pharmacovigilance panel made recommendations for updated label warnings for a variety of products. Read More

Judge Turns Down Abbott’s Motion in Depakote Birth Defects Case

An Illinois judge denied a request from Abbott Laboratories to throw out a suit accusing the drugmaker of failing to properly warn of safety risks associated with its drug Depakote. Read More

Tennessee Judge Denies Endo Request to Move Opioid Lawsuit to Federal Court

A Tennessee judge denied Endo Pharmaceuticals’ request to move a lawsuit against opioid makers from state to federal court. Read More

Compounder Missed Marks for Sterile Drug Processing, FDA Says

An Alabama compounding pharmacy fell short of several standards for sterile drug processing, the FDA said in a Form 483 inspection report. Read More